Literature DB >> 12455722

C-reactive-protein and cytokine plasma levels in hemodialysis patients.

Olaf Boenisch1, Klaus-Dieter Ehmke, Adalbert Heddergott, Claudia Naoum, Ulrich Frei, Ralf Schindler.   

Abstract

BACKGROUND: Markers of an acute phase reaction, such as C-reactive protein (CRP) or interleukin-6 (IL-6), are predictive for cardiovascular morbidity and mortality in normal subjects and in hemodialysis (HD) patients. Le-vels of acute phase proteins (APP) may vary with time even in the absence of an acute illness and this may weaken the relationship between APP and clinical outcome. We investigated the intra- and inter-individual patterns of several inflammatory markers in HD patients.
METHODS: Plasma levels of CRP, IL-10, RANTES, TNF-RI, leptin, ferritin and albumin were measured weekly for 12 weeks after the long inter-dialytic interval by ELISA in ten stable HD patients with no clinical signs of infection.
RESULTS: Considerable variability was observed. Intra-individual differences were largest for RANTES (coefficient of variation - CV - 80%, followed by CRP (51%), and low for albumin (11%) and ferritin (12%). Inter-individual variability was highest for IL-10 (135%) followed by CRP (88%).
CONCLUSIONS: The present data suggest that single point measurements of APP, particularly CRP, may not be sufficient to assess the cardiovascular risk in HD patients. Even in patients with no apparent signs of infection, there is considerable variability in plasma levels of APP and repeated measurements are recommended to identify patients at high cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12455722

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

1.  Plasma levels of resistin-like molecule beta in humans.

Authors:  Andrew P Neilson; Zora Djuric; Susan Land; Ikuko Kato
Journal:  Cancer Epidemiol       Date:  2010-11-19       Impact factor: 2.984

2.  C-reactive protein levels in patients on maintenance hemodialysis: reliability and reflection on the utility of single measurements.

Authors:  Caroline E Stigant; Ognjenka Djurdjev; Adeera Levin
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis.

Authors:  Yildiz Oner-Iyidogan; Pernur Oner; Hikmet Kocak; Figen Gurdol; Seldag Bekpinar; Yesim Unlucerci; Yasar Caliskan; Pinar Cetinalp-Demircan; Taner Kocak; Aydin Turkmen
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

4.  Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study.

Authors:  Wilfried Karmaus; Plamen Dimitrov; Valeri Simeonov; Svetla Tsolova; Vecihi Batuman
Journal:  BMC Nephrol       Date:  2009-04-28       Impact factor: 2.388

5.  The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.

Authors:  Ali Borazan; Hasan Ustün; Yucel Ustundag; Selim Aydemir; Taner Bayraktaroglu; Mehmet Sert; Ahmet Yilmaz
Journal:  Mediators Inflamm       Date:  2004-06       Impact factor: 4.711

Review 6.  Periodontitis, Low-Grade Inflammation and Systemic Health: A Scoping Review.

Authors:  Gennaro Cecoro; Marco Annunziata; Morena Tina Iuorio; Livia Nastri; Luigi Guida
Journal:  Medicina (Kaunas)       Date:  2020-05-30       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.